Skip to content
The Policy VaultThe Policy Vault

Revlimid — Medica

Myelofibrosis

Initial criteria

  • Option A: age ≥ 18 years AND anemia per prescriber AND serum erythropoietin ≥ 500 mU/mL
  • OR Option B: age ≥ 18 years AND anemia per prescriber AND serum erythropoietin < 500 mU/mL AND no response or loss of response to an erythropoiesis-stimulating agent

Approval duration

3 years